Salman R Punekar

9PUBLICATIONS
99CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer geneticsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 11, 2026
Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer.

|Jun 29, 2026
Current Roles of Neoadjuvant and Perioperative Immunotherapy in Non-Small Cell Lung Cancer.

|May 20, 2026
Cellular Therapies in Solid Tumors: Are We Ready for Primetime?

|May 08, 2026
Mutant Selective T-Cell Receptor Therapy for Solid Tumors.

|Aug 29, 2025
TNG260 Is a Small-Molecule CoREST Inhibitor That Sensitizes STK11-Mutant Tumors to Anti-PD-1 Immunotherapy.

Leanne G Ahronian, Soumyadip Sahu, Minjie Zhang

|May 03, 2023
In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancer.

Jiehui Deng, David H Peng, David Fenyo

Pageof 2

Frequent Collaborators

2 joint publications

Jiehui Deng

2 joint publications

Kwok-Kin Wong

2 joint publications

Soumyadip Sahu

2 joint publications

Michela Ranieri